Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (421-430 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217J J Cook, M A Holahan, E A Lyle, et al.
Journal of Medicinal Chemistry|June 6, 1997
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonistsB C Askew, R A Bednar, B Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2007
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinaseRobert M Garbaccio, Shaei Huang, Edward S Tasber, et al.
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosisPaul J Coleman, Karen M Brashear, Ben C Askew, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Pyridyl amides as potent inhibitors of T-type calcium channelsThomas S Reger, Zhi-Qiang Yang, Kelly-Ann S Schlegel, et al.
Chemmedchem|May 7, 2009
Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in ratsDavid B Whitman, Christopher D Cox, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2009
Development of thioquinazolinones, allosteric Chk1 kinase inhibitorsAntonella Converso, Timothy Hartingh, Robert M Garbaccio, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Pageof 46

Showing results (421-430 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217J J Cook, M A Holahan, E A Lyle, et al.
Journal of Medicinal Chemistry|June 6, 1997
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonistsB C Askew, R A Bednar, B Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2007
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinaseRobert M Garbaccio, Shaei Huang, Edward S Tasber, et al.
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosisPaul J Coleman, Karen M Brashear, Ben C Askew, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Pyridyl amides as potent inhibitors of T-type calcium channelsThomas S Reger, Zhi-Qiang Yang, Kelly-Ann S Schlegel, et al.
Chemmedchem|May 7, 2009
Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in ratsDavid B Whitman, Christopher D Cox, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2009
Development of thioquinazolinones, allosteric Chk1 kinase inhibitorsAntonella Converso, Timothy Hartingh, Robert M Garbaccio, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Pageof 46